Skip to main content

Identifying relevant compounds in patents

 


As you may know, patents can be inherently noisy documents which can make it challenging to extract drug discovery information from them, such as the key targets or compounds being claimed. There are many reasons for this, ranging from deliberate obfuscation through to the long and detailed nature of the documents. For example, a typical small molecule patent may contain extensive background information relating to the target biology and disease area, chemical synthesis information, biological assay protocols and pharmacological measurements (which may refer to endogenous substances, existing therapies, reaction intermediates, reagents and reference compounds), in addition to description of the claimed compounds themselves. 

The SureChEMBL system extracts this chemical information from patent documents through recognition of chemical names, conversion of images and extraction of attached files, and allows patents to be searched for chemical structures of interest. However, the current SureChEMBL data extraction pipeline cannot distinguish between the different types of chemicals described in a patent document - it simply extracts all identified molecules. Some simple metrics can be used to filter out the worst offenders. For example, the corpus frequency can be used to remove molecules that are seen thousands of times over many patents (not novel) and chemical descriptors can be used to filter molecules that are particularly small (e.g., fragments, ions, solvents) or don't have drug-like properties. However, there is still much room for improvement and a need for additional methods to more accurately identify claimed compounds.

This paper on the 'Identification of the Core Chemical Structure in SureChEMBL Patents' has recently been published by Maria Falaguera and Jordi Mestres, and the resulting data set is available to download from the SureChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/SureChEMBLccs. The paper describes a filtering protocol to automatically select the core chemical structures best describing the pharmacologically relevant molecules in a patent. The method is based on identifying maximum common substructures (MCSs) for all compounds in a patent, using RDKit. These are filtered to remove those that are particularly promiscuous, then candidate MCSs are chosen according to coverage, homogeneity and inclusion criteria, to identify those that are most likely to represent the core chemical structure of the patent claim. These candidate MCSs are then used to retain only molecules from the patent that contain at least one such substructure (or those with high similarity to a molecule that does). 

The method has been validated against a set of patents containing pharmacology data that have been manually extracted for inclusion in ChEMBL. Since the compounds included in ChEMBL all have reported activity measurements in the patents, it is reasonable to assume these are highly relevant molecules. The filtering method was able to recover 92.5% of these molecules from the corresponding patents (see the paper for lots more detail on this). Finally, the method was then run on the set of 240K US patents with medical classification codes (A61K*, excluding dental, cosmetic, antibodies etc), resulting in a set of 5.9m molecules that form closely related chemical series (65.3% of the total molecules). As mentioned above, this data set can be downloaded from SureChEMBL.

We'd be keen to hear from anyone who finds this data useful; we are actively exploring a number of different ways to improve the SureChEMBL system including the accuracy of its annotations. 

Comments

Popular posts from this blog

ChEMBL 31 is out!

  We are pleased to announce the release of ChEMBL 31! This version of the database, prepared on 12/07/2022 contains: 2,967,627 compound records 2,331,700 compounds (of which 2,304,875 have mol files) 19,780,369 activities 1,498,681 assays 15,072 targets 85,431 documents New Data Sources MMV Malaria HGL Fraunhofer HDAC6 Updated Data Sources Scientific Literature Patent Bioactivity Data Donated Chemical Probes - SGC Frankfurt EUbOpen Chemogenomic Library Newly Deposited Datasets CHEMBL4888484 - Replenishing the malaria drug discovery pipeline CHEMBL4808148 - HDAC6 screening dataset CHEMBL4879553 - Data for DCP probe BAY1125976 CHEMBL4879554 - Data for DCP probe GNE-2256 Database changes since the last release: No schema changes. Funding acknowledgements Work contributing to ChEMBL31 was funded by the Wellcome Trust,  EMBL Member States, Open Targets, National Institutes of Health (NIH),  EU Innovative Medicines Initiative (IMI)

LSH-based similarity search in MongoDB is faster than postgres cartridge.

TL;DR: In his excellent blog post , Matt Swain described the implementation of compound similarity searches in MongoDB . Unfortunately, Matt's approach had suboptimal ( polynomial ) time complexity with respect to decreasing similarity thresholds, which renders unsuitable for production environments. In this article, we improve on the method by enhancing it with Locality Sensitive Hashing algorithm, which significantly reduces query time and outperforms RDKit PostgreSQL cartridge . myChEMBL 21 - NoSQL edition    Given that NoSQL technologies applied to computational chemistry and cheminformatics are gaining traction and popularity, we decided to include a taster in future myChEMBL releases. Two especially appealing technologies are Neo4j and MongoDB . The former is a graph database and the latter is a BSON document storage. We would like to provide IPython notebook -based tutorials explaining how to use this software to deal with common cheminformatics p

ChEMBL 30 released

  We are pleased to announce the release of ChEMBL 30. This version of the database, prepared on 22/02/2022 contains: 2,786,911 compound records 2,157,379 compounds (of which 2,136,187 have mol files) 19,286,751 activities 1,458,215 assays 14,855 targets 84,092 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_30/ Please see ChEMBL_30 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_30/chembl_30_release_notes.txt New Deposited Datasets EUbOPEN Chemogenomic Library (src_id = 55, ChEMBL Document ID CHEMBL4689842):   The EUbOPEN consortium is an Innovative Medicines Initiative (IMI) funded project to enable and unlock biology in the open. The aims of the project are to assemble an open access chemogenomic library comprising about 5,000 well annotated compounds covering roughly 1,000 different proteins, to synthesize at least

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d